NCT05432336

Brief Summary

The purpose of this study is to evaluate the impact of different technique to optimize the microbiological diagnosis of the COI.

  • Metagenomic for the endophtalmitis
  • Multiplex polymerase chain reaction for corneal abscesses

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
153

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 12, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 27, 2022

Completed
1.4 years until next milestone

Study Start

First participant enrolled

November 21, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 17, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

September 15, 2025

Status Verified

September 1, 2025

Enrollment Period

1.7 years

First QC Date

May 12, 2022

Last Update Submit

September 8, 2025

Conditions

Keywords

Endogenous Endophtalmitisexogenous endophtalmitiskeratitisPCRNGS

Outcome Measures

Primary Outcomes (1)

  • Positivity rates of COI samples according to the new protocol

    Before/after type comparison. Comparison of the positivity rates of COI samples according to the new protocol: (i) for endophthalmitis performing a vitreous puncture (PV) or an anterior chamber puncture (PCA), or corneal scraping, optimized with modification of microbiological techniques (culture on enriched medium alone associated with shotgun metagenomics), (ii) for severe corneal abscesses, addition to standard microbiological techniques of molecular biology tests (multiplex PCR and / or metagenomics). An COI will be considered with a positive microbiological diagnosis after multidisciplinary concertation considering the different results

    2 weeks after taking samples

Secondary Outcomes (6)

  • Microbiological diagnosis of the infection

    At the end of the follow up: 18 months

  • Time to microbiological diagnosis according to the different technic

    At the end of the follow up: 18 months

  • Accuracy of the different technics according to the gold standard (microbiological culture)

    At the end of the follow up: 18 months

  • Visual acuity

    At the end of the follow up: 18 months

  • Cure rate

    At the end of the follow up: 18 months

  • +1 more secondary outcomes

Study Arms (1)

Complex ocular infections (COI)

All patients with an COI (endophtalmitis or hospitalized keratitis)

Diagnostic Test: NGS for endohtalmitis / Multiplex PCR for keratitis

Interventions

For endophtalmitis : optimizing culture and NGS will be realized For keratitis: Multiplex PCR will be added on ocular samples

Also known as: Bundle of intervervention to optimizing diagnosis of ocular complex infections
Complex ocular infections (COI)

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient presenting or having presented a clinical suspicion of complex ocular infection requiring a sample for microbiological diagnosis

You may qualify if:

  • Adult patient
  • Patient presenting or having presented a clinical suspicion of complex ocular infection requiring a sample for microbiological diagnosis:
  • Corneal abscess requiring hospitalization
  • Any suspicion of endogenous or exogenous endophthalmitis.
  • Patient not opposed to participating in the research

You may not qualify if:

  • Patient under guardianship or curatorship
  • Pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Equipe mobile d'infectiologie, Cochin hospital

Paris, IDF, 75014, France

RECRUITING

MeSH Terms

Conditions

EndophthalmitisKeratitis

Condition Hierarchy (Ancestors)

Eye InfectionsInfectionsEye DiseasesCorneal Diseases

Study Officials

  • Etienne CANOUI, MD

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Etienne CANOUI, MD

CONTACT

Marie BENHAMMANI-GODARD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 12, 2022

First Posted

June 27, 2022

Study Start

November 21, 2023

Primary Completion

July 17, 2025

Study Completion

January 1, 2026

Last Updated

September 15, 2025

Record last verified: 2025-09

Locations